Global CAR T-Cell therapy Market Size study & Forecast, by Indication, By Drug Type, By End user, and Regional Analysis, 2023-2030

Description

List of Tables

Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimeric antigen receptor (CAR) T cell therapy is a novel form of cancer therapy in which medical experts modify T cells in a lab before injecting them into cancer patients' bodies to enable them to detect and eliminate cancer cells. The immune system is trained to recognize malignant cells by CAR T-cell therapy. The immune response against malignant cells is boosted by CAR T-cell treatment. The market for CAR T-cell therapy is primarily driven by an increase in the demand for suitable therapeutics for the treatment of cancer, favorable reimbursement policies for CAR T-cell therapy medications in some countries, and an increase in consumer awareness of CAR T-cell therapy medications. Additionally, the recent commercialization of CAR-T cell therapy and the surging clinical trial activities are further influencing the market expansion.

In addition, an increase in the incidence of cancer such as leukemia and lymphoma are directly augmenting the demand for CAR T-Cell therapy. According to World Health Organization (WHO), in 2020, the number of leukemia cancer cases is estimated to account for 475 thousand, which is projected to reach 692 thousand patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for a wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the CAR T-Cell therapy Market. Moreover, the growing investment in research and development, as well as increasing advancements in technology present various lucrative opportunities over the forecasting years. However, the unavailability of skilled professionals and the high cost of developing CAR T-cell therapy are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global CAR T-Cell therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing regulatory approvals, growing investment in advancing healthcare facilities, and rising technological developments. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising prevalence of cancer, increasing research funding for novel therapeutics by government bodies, and growing awareness and increase in approval of novel medications are significantly propelling the market demand across the region.

Major market players included in this report are:

Autolus Therapeutics
Bluebird bio, Inc.
Bristol-Myers Squibb
Caribou Biosciences, Inc.
Cartesian Therapeutics, Inc.
Celgene Corporation
Gilead Sciences, Inc. (Kite Pharma Inc.)
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.

Recent Developments in the Market:

In June 2022, Bristol-Myers Squibb Company announced that the company received the U.S. Food and Drug Administration (FDA) approval for Breyanzi CAR T cell therapy to cure refractory or relapsed large B-cell lymphoma after one prior therapy. The Phase 2 pilot company-sponsored research of a CAR T cell treatment in patients with primary refractory or relapsed LBCL served as the foundation for the approval.
In February 2022, Johnson & Johnson Services, Inc. declared that the U.S. Food and Drug Administration had approved CARVYKTI (ciltacabtagene autoleucel), a BCMA-Directed CAR-T Immunotherapy for the treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Global CAR T-Cell therapy Market Report Scope:

Historical Data: - 2020 - 2021
Base Year for Estimation: - 2022
Forecast period: - 2023-2030
Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: - Indication, Drug type, End user, Region
Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Indication:

Lymphoma
Acute Lymphocytic Leukemia
Others

By Drug type:

Axicabtagene Ciloleucel
Tisagenlecleucel
Brexucabtagene Autoleucel
Others

By End-user:

Hospitals
Cancer Treatment Centers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. CAR T-Cell therapy Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. CAR T-Cell therapy Market, by Indication, 2020-2030 (USD Billion)
- 1.2.3. CAR T-Cell therapy Market, by Drug type, 2020-2030 (USD Billion)
- 1.2.4. CAR T-Cell therapy Market, by End user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global CAR T-Cell therapy Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global CAR T-Cell therapy Market Dynamics

3.1. CAR T-Cell therapy Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increase in the incidence of cancer such as leukemia and lymphoma
  - 3.1.1.2. Favorable reimbursement policies for CAR T-cell therapy medications
- 3.1.2. Market Challenges
  - 3.1.2.1. Unavailability of skilled professionals
  - 3.1.2.2. High cost of developing CAR T-cell therapy
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing investment in research and development
  - 3.1.3.2. Increasing advancements in technology

Chapter 4. Global CAR T-Cell therapy Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global CAR T-Cell therapy Market, by Indication

5.1. Market Snapshot
5.2. Global CAR T-Cell therapy Market by Indication, Performance - Potential Analysis
5.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. CAR T-Cell therapy Market, Sub Segment Analysis
- 5.4.1. Lymphoma
- 5.4.2. Acute Lymphocytic Leukemia
- 5.4.3. Others

Chapter 6. Global CAR T-Cell therapy Market, by Drug type

6.1. Market Snapshot
6.2. Global CAR T-Cell therapy Market by Drug type, Performance - Potential Analysis
6.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Drug type 2020-2030 (USD Billion)
6.4. CAR T-Cell therapy Market, Sub Segment Analysis
- 6.4.1. Axicabtagene Ciloleucel
- 6.4.2. Tisagenlecleucel
- 6.4.3. Brexucabtagene Autoleucel
- 6.4.4. Others

Chapter 7. Global CAR T-Cell therapy Market, by End user

7.1. Market Snapshot
7.2. Global CAR T-Cell therapy Market by End user, Performance - Potential Analysis
7.3. Global CAR T-Cell therapy Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
7.4. CAR T-Cell therapy Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Cancer Treatment Centers

Chapter 8. Global CAR T-Cell therapy Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. CAR T-Cell therapy Market, Regional Market Snapshot
8.4. North America CAR T-Cell therapy Market
- 8.4.1. U.S. CAR T-Cell therapy Market
  - 8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Drug type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada CAR T-Cell therapy Market
8.5. Europe CAR T-Cell therapy Market Snapshot
- 8.5.1. U.K. CAR T-Cell therapy Market
- 8.5.2. Germany CAR T-Cell therapy Market
- 8.5.3. France CAR T-Cell therapy Market
- 8.5.4. Spain CAR T-Cell therapy Market
- 8.5.5. Italy CAR T-Cell therapy Market
- 8.5.6. Rest of Europe CAR T-Cell therapy Market
8.6. Asia-Pacific CAR T-Cell therapy Market Snapshot
- 8.6.1. China CAR T-Cell therapy Market
- 8.6.2. India CAR T-Cell therapy Market
- 8.6.3. Japan CAR T-Cell therapy Market
- 8.6.4. Australia CAR T-Cell therapy Market
- 8.6.5. South Korea CAR T-Cell therapy Market
- 8.6.6. Rest of Asia Pacific CAR T-Cell therapy Market
8.7. Latin America CAR T-Cell therapy Market Snapshot
- 8.7.1. Brazil CAR T-Cell therapy Market
- 8.7.2. Mexico CAR T-Cell therapy Market
8.8. Middle East & Africa CAR T-Cell therapy Market
- 8.8.1. Saudi Arabia CAR T-Cell therapy Market
- 8.8.2. South Africa CAR T-Cell therapy Market
- 8.8.3. Rest of Middle East & Africa CAR T-Cell therapy Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Autolus Therapeutics
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Bluebird bio, Inc.
- 9.3.3. Bristol-Myers Squibb
- 9.3.4. Caribou Biosciences, Inc.
- 9.3.5. Cartesian Therapeutics, Inc.
- 9.3.6. Celgene Corporation
- 9.3.7. Gilead Sciences, Inc. (Kite Pharma Inc.)
- 9.3.8. Merck & Co., Inc.
- 9.3.9. Novartis AG
- 9.3.10. Pfizer, Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global CAR T-Cell therapy Market, report scope
TABLE 2. Global CAR T-Cell therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global CAR T-Cell therapy Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 4. Global CAR T-Cell therapy Market estimates & forecasts by Drug type 2020-2030 (USD Billion)
TABLE 5. Global CAR T-Cell therapy Market estimates & forecasts by End user 2020-2030 (USD Billion)
TABLE 6. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global CAR T-Cell therapy Market
TABLE 71. List of primary sources, used in the study of global CAR T-Cell therapy Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global CAR T-Cell therapy Market, research methodology
FIG 2. Global CAR T-Cell therapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global CAR T-Cell therapy Market, key trends 2022
FIG 5. Global CAR T-Cell therapy Market, growth prospects 2023-2030
FIG 6. Global CAR T-Cell therapy Market, porters 5 force model
FIG 7. Global CAR T-Cell therapy Market, pest analysis
FIG 8. Global CAR T-Cell therapy Market, value chain analysis
FIG 9. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global CAR T-Cell therapy Market, regional snapshot 2020 & 2030
FIG 15. North America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 16. Europe CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 18. Latin America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa CAR T-Cell therapy Market 2020 & 2030 (USD Billion)